None listed
Conditions
Interventions
Dietary Supplement : Subjects will be randomized to receive Fingerroot(Bosenbergia pandurata) 300mg, 600mg or placebo. Subjets will orally self-adminster Fingerroot(Bosenbergia pandurata) 300mg, 600mg
Sponsors
Newtree
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Male and female subjects between 20-65years of age inclusive. 2) BMI of 25.0-29.9kg/m2 3) Evidense of a personally signed and dated informed consent document indicating that the subject has been informed of all pertinent aspects of the trial.
Exclusion criteria
Exclusion criteria: 1. Subjects with systolicBP = 160 mmHg or diastolicBP = 100 mmHg and also taking a beta blocker or a hydragogue. 2. Subjects with diabetes(use of hypoglycemic agent or insulin)or fasting blood glucose = 126 mg/dL or random blood glucose = 200 mg/dL. 3. Subjects with endocrinopathy or abnormal screening TSH value(=0.1uU/ml or =10 uU/ml). 4. Serum AST/ALT = 3 times the upper limit of normal. 5. Serum creatinine = 2 times the upper limit of normal. 6. Use of prescription drugs or supplements known to alter body weight or appetite, antidepressants, oral contraceptive, steroid, female sex hormon. 7. Subjets with clinically significant cardiovascular disease within the 6 months prior to screening. 8. Subjets with a history of cancer and intervention within the 5 years prior to screening. 9. Subjects with a history of CNS disorder(depressivedisorder,schizophrenia, alcoholism, drug addiction). 10. Women of childbearing age who are disagreed with effective contraceptions in the clinical trial period. 11. Woman who are pregnant or lactating. 12. Participation in any clinical trial within the 3 months prior to screening. 13. Subjects with bleeding risk factor of stomach. 14. Subjects with the musculoskeletal disorders or restricted physical activity. 15. Subjects who could affect preclude evauation of response in the opinion investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in body weight ;Chainge in fat percentage(by DEXA) ;Chainge in fat mass(by DEXA) | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in visceral fat(by CT) ;Change in subcutaneous fat(by CT) ;Change in waist circumference | — |
Countries
Korea, Republic of
Contacts
Public ContactYangim Hur
Inje University Seoul Paik Hospital
Outcome results
None listed